Jos Melenhorst

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia

Noelle V. Frey, Pamela A. Shaw, Elizabeth O. Hexner et al. · Journal of Clinical Oncology · 2019 · 269 citations · Full text

Life Sciences, Immunology, Oncology +17

CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy

Vinodh Pillai, Kavitha Muralidharan, Wenzhao Meng et al. · Blood Advances · 2019 · 202 citations · Full text

Medicine, Hematology, Oncology +16

Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity

Alana A. Kennedy‐Nasser, Stephanie Ku, Paul Castillo‐Caro et al. · Clinical Cancer Research · 2014 · 201 citations · Full text

Life Sciences, Hematology, Immunology +10

The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D–target-cell interactions

Giuseppe Sconocchia, Michelle Lau, Maurizio Provenzano et al. · Blood · 2005 · 83 citations · Full text

Life Sciences, Hematology, Immunology +14

T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus

Jongming Li, Jos Melenhorst, Nancy F. Hensel et al. · Journal of General Virology · 2006 · 72 citations

Life Sciences, Immunology, Infectious Diseases +17